PBSV Stock Pharma-Bio Serv (PBSV, $0.59) Aroon Indicator entered a Downtrend on February 04, 2026.
at Tickeron.com
For the last three days, A.I.dvisor has detected that PBSV's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong downtrend ahead for PBSV, and traders may view it as a Sell signal for the next month. Traders may consider selling the stock or exploring put options. A.I.dvisor backtested this indicator and found 116 similar cases, of which were successful. Based on this data, the odds of success are
PBSV sees its 50-day moving average cross bearishly below its 200-day moving average
The 50-day moving average for PBSV moved below the 200-day moving average on January 13, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The 10-day moving average for PBSV crossed bearishly below the 50-day moving average on January 14, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 23 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PBSV declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
PBSV broke above its upper Bollinger Band on January 30, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for PBSV entered a downward trend on February 04, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where PBSV's RSI Oscillator exited the oversold zone, of 22 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on January 27, 2026. You may want to consider a long position or call options on PBSV as a result. In of 146 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for PBSV just turned positive on January 28, 2026. Looking at past instances where PBSV's MACD turned positive, the stock continued to rise in of 78 cases over the following month. The odds of a continued upward trend are .
PBSV moved above its 50-day moving average on January 30, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where PBSV advanced for three days, in of 67 cases, the price rose further within the following month. The odds of a continued upward trend are .
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. PBSV’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.134) is normal, around the industry mean (19.121). P/E Ratio (20.231) is within average values for comparable stocks, (99.967). PBSV's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.990). PBSV has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.030). P/S Ratio (1.505) is also within normal values, averaging (64.502).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PBSV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 98, placing this stock worse than average.
Advertisement
General Information
Industry ServicestotheHealthIndustry